All Sauce from Weekly Sauce:

Hormone replacement therapy might help women avoid depression as they go through menopause, a new study finds. Women treated with hormone therapy at a menopause clinic in Ontario, Canada, experienced a reduction in their symptoms of depression, researchers report Feb. 21 in the journal Menopause. This improvement occurred whether or not antidepressants were also prescribed,…  read on >  read on >

In a finding that suggests sooner is better than later, a new trial shows that giving advanced treatment early to Crohn’s patients can dramatically improve their gut health. About 80% of those who got therapy with an immune-suppressing drug called infliximab shortly after their Crohn’s diagnosis experienced an improvement in their symptoms and inflammatory markers…  read on >  read on >

After states legalize the sale of weed for recreational use, on-the-job injuries rise among younger workers, new research shows. U.S. Bureau of Labor statistics for 2006 through 2020 show that legal “recreational marijuana sales were associated with a 10% increase in workplace injuries among individuals aged 20 to 34 years,” the study authors concluded. They…  read on >  read on >

An open question for weight-loss drugs like Ozempic, Wegovy and Zepbound has been whether folks will keep the pounds off when they stop taking them. Regular exercise could be the key to quitting the drugs without regaining weight, a new Danish study says. “It is actually possible to stop taking the medication without large weight…  read on >  read on >

A “universal” antivenom can block the lethal toxins in the venoms of a wide variety of poisonous snakes found in Africa, Asia and Australia, researchers report. The antibody protected mice from the normally deadly venom of snakes like black mambas and king cobras, according to findings published Feb. 21 in the journal Science Translational Medicine.…  read on >  read on >

FRIDAY, Feb. 23, 2024 (HealthDay news) — Artificial intelligence can match and even outperform human eye doctors in diagnosing and treating glaucoma, a new study finds. The GPT-4 system from OpenAI did as well or better than ophthalmologists in assessing 20 different patients for glaucoma and retinal disease, researchers report Feb. 22 in the journal…  read on >  read on >